New hope for kids with cancer: cord blood transplant trial seeks to control deadly diseases
NCT ID NCT04644016
Summary
This study is testing a cord blood transplant for children and young adults (up to age 21) with life-threatening blood cancers and disorders who do not have a perfectly matched donor. The main goal is to see how safe the procedure is by measuring the risk of death from the treatment itself within one year. Researchers hope this approach can help control these serious diseases when other donor options are not available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.